Zoe Daniels - Concepedia

Author

Zoe Daniels

Granta Design (United Kingdom)

Also Known As

Zoe Daniels, Zoe Marie Daniels

Publications

Citations

H-Index

Concepts

All Affiliations

Granta Design (United Kingdom)Servier (France)

About

Zoe Daniels is an author at Granta Design (United Kingdom) specializing in medicine, medicinal chemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	461
2	Natural Sciences	3	3	329
3	Biochemistry	2	2	232
4	Cell Biology	2	2	354
5	Cellular Physiology	1	1	27

Zoe Daniels

Publications

852

Citations

H-Index

Page 1

	Year	Citations
A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells Andrew J. Massey, D.S. Williamson, Helen Browne, Cancer Chemotherapy and Pharmacology MedicineApoptosisCell DeathSmall Molecule InhibitorHsp90 Inhibitor	2009	327
Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design D.S. Williamson, Jenifer Borgognoni, Alexandra Clay, Journal of Medicinal Chemistry Protein ChemistryMedicinal ChemistryProtein FunctionProtein AssemblyBiochemistry	2009	222
Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity Alba T. Macias, D.S. Williamson, Nicola J. Allen, Journal of Medicinal Chemistry	2011	112
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor Zoltán Szlávik, Márton Csékei, Attila Paczal, Journal of Medicinal Chemistry Molecular DockingTumor BiologyMedicinal ChemistryDrug TargetHindered Rotation	2020	97
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1) D.S. Williamson, Garrick P. Smith, P. Acheson-Dossang, Journal of Medicinal Chemistry	2017	47
Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells Lodewijk V. Dekker, Zoe Daniels, Caroline A. Hick, European Journal of Pharmacology Molecular PhysiologyHuman Nav1.8Molecular NeurobiologyMedicineCell Biology	2005	27
Fatty acid amide hydrolase inhibitors. 3: Tetra-substituted azetidine ureas with in vivo activity Stephen D. Roughley, Helen Browne, Alba T. Macias, Bioorganic & Medicinal Chemistry Letters Tetra-substituted Azetidine UreasMedicinal ChemistryVivo ActivityBiochemistryNatural Sciences	2011	10
Abstract 1276: Identification of S65487/VOB560 as a potent and selective intravenous 2nd-generation BCL-2 inhibitor active in wild-type and clinical mutants resistant to Venetoclax Arnaud LeTiran, Audrey Clapéron, James Davidson, Cancer Research	2021	10

Page 1